查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965468

器官保存液市場－全球產業規模、佔有率、趨勢、機會、預測：按器官類型、應用、區域和競爭格局分類，2021-2031年

Organ Preservation Solution Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Organ Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球器官保存解決方案市場預計將從 2025 年的 2.8124 億美元成長到 2031 年的 4.2006 億美元，複合年成長率達到 6.92%。

這些解決方案包括專門研發的藥物配方，旨在維持細胞活力並減輕器官捐贈至移植期間的缺血性損傷。該市場的成長主要歸因於慢性疾病和老化導致的末期器官衰竭發生率不斷上升，推動了對移植手術的潛在需求。此外，器官捐贈網路的擴展和長途運輸物流系統的加強也促進了這些保存液的持續使用，因為醫療機構致力於提高移植器官的存活率。

市場概覽
預測期 2027-2031
市場規模：2025年 2.8124億美元
市場規模：2031年 4.2006億美元
複合年成長率：2026-2031年 6.92%
成長最快的細分市場 威斯康辛大學解決方案（UW Solutions）
最大的市場 北美洲

然而，器官需求旺盛而供體數量有限之間的持續缺口，對市場潛力構成重大阻礙。根據全球器官捐贈和移植觀察站的數據，截至2024年，全球共進行了172,397例固態器官移植手術。這一數字表明，儘管移植活動持續進行，但可用器官的固有短缺限制了對器官保存解決方案的總需求，從而阻礙了更廣泛的市場成長。

市場促進因素

器官灌注和保存技術的進步正在從根本上改變市場結構，延長捐贈器官的存活時間，並促進邊緣捐贈者的利用。目前，器官保存方式正從靜態冷凍保存到動態機械灌注系統中發生顯著轉變，後者可在運輸過程中維持器官的代謝活性。這項轉變正在改善移植後的預後，並顯著擴大癌症後死亡（DCD）捐贈者器官移植的應用範圍。這些創新成果的影響已在近期數據中反映出來。根據美國衛生資源與服務管理局（HRSA）於2025年1月發布的《2024年器官捐贈與移植資料》，2024年美國DCD捐贈者數量較去年同期增加23.5%，此成長主要得益於先進的臨床保存技術。

同時，全球器官移植手術數量的不斷成長是推動保存液消耗量上升的主要因素。隨著醫療基礎設施的進步和國際捐贈網路效率的提高，需要使用藥物保存液的手術總數也增加。根據美國器官移植網路（UNOS）於2025年1月發布的《2024年移植統計數據》，2024年美國共進行了48,149例器官移植手術，較去年同期成長3.3%，增幅顯著。儘管手術數量增加，慢性器官衰竭的發生率仍超過器官供應量，凸顯了尋找提高移植器官存活率解決方案的必要性。例如，根據英國國家醫療服務體系（NHS）血液和移植組織於2025年11月發布的《英國最新統計數據》，英國仍有8,237名患者在等待器官移植，這更加凸顯了有效保存技術的迫切需求。

市場挑戰

移植保存液市場商業性規模的主要阻礙因素是供體器官的稀少性。由於這些藥物產品是移植過程中器官取得和運輸階段的消耗品，其市場滲透率直接取決於可用移植器官的數量。因此，製造商的獲利能力受捐贈者器官供應的限制，而非末期器官衰竭患者的臨床需求。所以，一旦器官供應達到飽和，無論疾病流行程度如何，保存液的採購量都將有不可避免的上限。

這種供需失衡造成了持續的瓶頸，限制了整體市場規模。根據器官取得和移植網路（OPTN）的數據，截至2024年1月，美國國家器官移植等待名單上有超過10.3萬名候選人。大量等待手術的患者與有限的捐贈器官供應之間存在巨大差距，阻礙了該行業為滿足患者需求而進行的擴張。這種失衡導致，儘管挽救生命的手術迫在眉睫，但保存液的銷售量仍將受限於每年的交付量。

市場趨勢

物聯網技術的引入和器官活力即時監測的實現，正在將被動式保存設備轉變為以數據為中心的智慧型設備，為市場樹立了新的標準。這一趨勢著重於透過基於應用程式的生態系統來保護供體器官，該系統持續監測溫度和位置等關鍵參數，從而降低因運輸過程中缺乏監控而帶來的風險。這項技術的臨床益處顯著。根據Paragonix Technologies公司於2024年4月發布的「GUARDIAN-Heart臨床註冊研究」報告，該公司先進的即時監測保存系統與傳統的冰凍保存相比，使兩年死亡率降低了43%。

同時，體外器官再生療法和治療方法的進步正從根本上改變器官保存策略，促進移植器官的主動修復，並顯著延長保存期。這些治療性灌注通訊協定不僅能維持器官功能，還能對關鍵器官進行功能調整，並提高移植手術安排的柔軟性，使手術從緊急手術轉向擇期手術。例如，XVIVO Perfusion公司在2024年1月的新聞稿（與發表在《採血針》上的一篇論文相關）中宣布，其低溫氧合灌注技術已成功將供肝的總保存時間延長至20小時，並在一年內實現了100%的患者和移植器官存活率。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球器官保存解決方案市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依器官類型（心臟、肺、腎臟、肝臟、其他）
    • 依應用方式（靜態低溫儲存、低溫機械灌注、常溫機械灌注等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美器官保存解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲器官保存解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區器官保存解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲器官保存解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲器官保存解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球器官保存解決方案市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life（Europe）Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc.
  • Vascular Perfusion Solutions, Inc.
  • Global Transplant Solutions

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23415

The Global Organ Preservation Solution Market is projected to expand from USD 281.24 Million in 2025 to USD 420.06 Million by 2031, achieving a CAGR of 6.92%. These solutions consist of specialized pharmacological formulations developed to sustain cellular viability and reduce ischemic damage in donor organs during the period between retrieval and transplantation. The market is primarily propelled by the rising incidence of end-stage organ failure caused by chronic illnesses and an aging demographic, which increases the fundamental need for transplant surgeries. Furthermore, the growth of organ donation networks and enhanced logistical systems for long-distance transport bolster the continued use of these preservation media as healthcare providers aim to optimize graft survival outcomes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 281.24 Million
Market Size 2031USD 420.06 Million
CAGR 2026-20316.92%
Fastest Growing SegmentUniversity of Wisconsin Solution (UW Solution)
Largest MarketNorth America

However, the persistent gap between the high demand for organs and the restricted supply of donors presents a major obstacle to market potential. Data from the Global Observatory on Donation and Transplantation indicates that 172,397 solid organ transplants were conducted worldwide in the year leading up to 2024. This figure highlights that although transplant activity remains strong, the inherent scarcity of viable organs restricts the total volume of preservation solutions required, thereby limiting broader market growth.

Market Driver

Technological progress in organ perfusion and preservation is fundamentally altering the market by prolonging donor organ viability and facilitating the use of marginal grafts. The sector is undergoing a notable shift from static cold storage to dynamic machine perfusion systems, which keep organs metabolically active during transport. This transition enhances post-transplant results and significantly widens the donor pool by rendering organs from Donors After Circulatory Death (DCD) more suitable for transplantation. The effect of these innovations is reflected in recent data; the Health Resources and Services Administration (HRSA), in its '2024 Organ Donation and Transplantation Data' from January 2025, noted a 23.5% increase in DCD donors in the United States in 2024 compared to the prior year, a rise driven by advanced clinical preservation methods.

At the same time, the increasing global volume of transplant procedures acts as a major driver for the consumption of preservation solutions. As healthcare infrastructure advances and international donor networks gain efficiency, the total number of surgeries requiring pharmacological preservation media has grown. According to the United Network for Organ Sharing (UNOS), in its '2024 Annual Transplant Statistics' released in January 2025, the United States reached a milestone with 48,149 transplants in 2024, marking a 3.3% increase over the previous year. Despite this growth in procedure volume, the rate of chronic organ failure continues to exceed organ supply, necessitating solutions that maximize graft survival; for example, NHS Blood and Transplant reported in 'Current UK Statistics' in November 2025 that 8,237 patients remain on the active waiting list in the United Kingdom, emphasizing the critical need for effective preservation.

Market Challenge

The shortage of viable donor organs serves as a primary limitation on the commercial volume of the organ preservation solution market. Because these pharmacological products are consumables used exclusively during the retrieval and transport stages of transplantation, their market uptake is directly tied to the number of available grafts. As a result, revenue potential for manufacturers is constrained by the supply of donor organs rather than the clinical demand from patients with end-stage organ failure. Consequently, when organ availability plateaus, the procurement volume of preservation media faces an unavoidable ceiling, irrespective of disease prevalence.

This imbalance between supply and demand creates a continuing bottleneck that limits the total addressable market. According to the Organ Procurement and Transplantation Network, there were over 103,000 candidates on the national transplant waiting list in the United States as of January 2024. This significant gap between the large number of patients awaiting surgery and the finite inventory of donor organs prevents the industry from scaling in alignment with patient needs. This disparity ensures that, despite the urgent requirement for life-saving procedures, the sales volume for preservation solutions remains confined to the limited number of donations achieved annually.

Market Trends

The adoption of IoT and real-time organ viability monitoring is setting a new benchmark in the market by transforming passive storage units into intelligent, data-centric devices. This trend centers on protecting donor grafts through app-based ecosystems that constantly monitor essential parameters like temperature and location, thereby reducing risks linked to unmonitored transport. The clinical benefit of this technology is significant; a report by Paragonix Technologies in April 2024, regarding the 'GUARDIAN-Heart Clinical Registry', indicated that using their advanced preservation system with real-time monitoring led to a 43% decrease in 2-year mortality rates compared to traditional ice storage.

Simultaneously, progress in ex-vivo organ rehabilitation and therapeutics is fundamentally changing preservation strategies by facilitating active graft repair and significantly extending storage durations. Beyond simple maintenance, these therapeutic perfusion protocols enable the reconditioning of marginal organs and provide greater flexibility in transplant scheduling, shifting procedures from emergency contexts to planned operations. Demonstrating this potential, XVIVO Perfusion announced in a January 2024 press release concerning a 'Lancet' publication that their hypothermic oxygenated perfusion technology successfully prolonged total donor liver preservation time to 20 hours, achieving 100% patient and graft survival at the one-year mark.

Key Market Players

  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life (Europe) Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc.
  • Vascular Perfusion Solutions, Inc.
  • Global Transplant Solutions

Report Scope

In this report, the Global Organ Preservation Solution Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Solution Market, By Organ Type

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

Organ Preservation Solution Market, By Application

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Others

Organ Preservation Solution Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Solution Market.

Available Customizations:

Global Organ Preservation Solution Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Preservation Solution Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Organ Type (Heart, Lung, Kidney, Liver, Others)
    • 5.2.2. By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Organ Preservation Solution Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Organ Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Organ Preservation Solution Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Organ Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Organ Preservation Solution Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Organ Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Organ Preservation Solution Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Organ Type
        • 6.3.3.2.2. By Application

7. Europe Organ Preservation Solution Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Organ Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Organ Preservation Solution Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Organ Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Organ Preservation Solution Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Organ Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Organ Preservation Solution Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Organ Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Organ Preservation Solution Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Organ Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Organ Preservation Solution Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Organ Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Organ Preservation Solution Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Organ Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Organ Preservation Solution Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Organ Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Organ Preservation Solution Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Organ Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Organ Preservation Solution Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Organ Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Organ Preservation Solution Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Organ Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Organ Preservation Solution Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Organ Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Organ Preservation Solution Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Organ Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Organ Preservation Solution Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Organ Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Organ Preservation Solution Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Organ Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Organ Preservation Solution Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Organ Type
        • 9.3.3.2.2. By Application

10. South America Organ Preservation Solution Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Organ Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Preservation Solution Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Organ Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Organ Preservation Solution Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Organ Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Organ Preservation Solution Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Organ Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Organ Preservation Solution Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Paragonix Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. XVIVO Perfusion AB
  • 15.3. Dr. Franz KOhler Chemie GmbH
  • 15.4. OrganOx Limited
  • 15.5. Bridge to Life (Europe) Ltd.
  • 15.6. Waters Medical Systems, LLC
  • 15.7. Preservation Solutions Inc.
  • 15.8. Artivion, Inc.
  • 15.9. Vascular Perfusion Solutions, Inc.
  • 15.10. Global Transplant Solutions

16. Strategic Recommendations

17. About Us & Disclaimer